Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-30

Clinical Trial Update: The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy. [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial investigates preoperative misoprostol for reducing blood loss during myomectomy in women with uterine fibroids, across Phase 2 and Phase 3, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Makerere University | Conditions: Uterine Fibroid | Phase 2, Phase 3 | Status: UNKNOWN